🏛️ Verified NIH Record • Updated 2026-02-20
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns (NCT04090424)
A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: PolyNovo Biomaterials Pty Ltd.
🩺 Plain-English Summary (8th-Grade Level)
This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable Temporizing Matrix (BTM).
Who can join: Review the eligibility criteria below.
Location: Valleywise Health — Phoenix, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (26 Sites)
Showing the first 25 of 26 sites.
- Valleywise Health — Phoenix, Arizona
- Southern California Regional Burn Center at LAC+USC — Los Angeles, California
- University of California Davis Medical Center — Sacramento, California
- Bridgeport Hospital — Bridgeport, Connecticut
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- Tampa General Hospital — Tampa, Florida
- Emory University at Grady Memorial Hospital — Atlanta, Georgia
- Loyola University of Chicago — Maywood, Illinois
- University of Iowa Hospital and Clinics — Iowa City, Iowa
- University of Kansas Hospital — Kansas City, Kansas
- University Medical Center, New Orleans — New Orleans, Louisiana
- Brigham and Women's Hospital — Boston, Massachusetts
- Massachusetts General Hospital — Boston, Massachusetts
- New York Presbyterian Weill Cornell Medicine — New York, New York
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
- Wake Forest Baptist Health — Winston-Salem, North Carolina
- Akron Children's Hospital, Burn Center — Akron, Ohio
- The Ohio State University/ Wexner Medical Center — Columbus, Ohio
- Lehigh Valley Hospital and Health Network — Allentown, Pennsylvania
- Temple University Hospital — Philadelphia, Pennsylvania
- University of Texas Southwestern Medical Center — Dallas, Texas
- Virginia Commonwealth University Medical Center — Richmond, Virginia
- UW Health University Hospital — Madison, Wisconsin
- Bembde Hospital — Aurangabad, Maharashtra
- National Burns Centre — Mumbai, Maharashtra
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Burns
- Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection — Oklahoma City, Oklahoma
- The Effects of Metformin on Morbidity and Mortality in Elderly Patients — Hamilton, Ontario
- A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells — Hamilton, Ontario
- A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes — Winnipeg, Manitoba
- 4-Aminopyridine to Treat Skin Burns — Tucson, Arizona
Explore by condition: All Burns clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.